<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Inven2</provider_name><provider_url>http://localhost:8080/2018</provider_url><author_name>klarsen</author_name><author_url>http://localhost:8080/2018/author/klarsen/</author_url><title>Melanoma cancer - Inven2</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="zaQp7XukES"&gt;&lt;a href="http://localhost:8080/2018/en/featured_item/melanoma-cancer/"&gt;Melanoma cancer&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="http://localhost:8080/2018/en/featured_item/melanoma-cancer/embed/#?secret=zaQp7XukES" width="600" height="338" title="&laquo;Melanoma cancer&raquo; &#x2014; Inven2" data-secret="zaQp7XukES" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>http://localhost:8080/2018/wp-content/uploads/2019/01/7i-iStock-499751098.jpg</thumbnail_url><thumbnail_width>1600</thumbnail_width><thumbnail_height>1067</thumbnail_height><description>Melanoma patients testing a new combination A trial being conducted worldwide allows patients with a number of different types of cancer to test a combination of two different immunotherapy drugs. In Norway, 36 people with serious melanoma, lung cancer and liver cancer, patients who would otherwise not have had access to effective treatment, have participated in the trial.</description></oembed>
